Julio Lamprea-montealegre
Works at
Lead investigator
Sources: openalex.org
Grants and prizes
GP1 Medications Among Individuals with CKM Disease, Real-world cardio-kidney effectiveness of GLP-1 and GLP-1/GIP add-on therapy among SGLT2 inhibitor users, 26GLPCKMD1643242, 2026–2028, 1 Jul 2026
Sources: openalex.org